AGT and Hyperglycemia: To simulate clinical observations in vitro, we subjected the senescent HAoSMCs to cardiovascular risk stimuli, such as angiotensin II (AngII)-simulating hypertension, CoCl2-simulating hypoxia and high glucose-simulating hyperglycemia.